Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think the upcoming 10 Q will make us happy campers.
WOW!!!!!!!
Awesome find.
So...Entest will be dedicated to finding new research protocols as part of divergent medicine, which may prove quite promising, especially with combining LLL with adipose stem cells for maximum healing.
So, we have Regen focused on blood cancer and HemaXellerate and ENTB focused on outside the box idea making, so does that mean that Dr. Koos is planning to use BMSN as an intermediate of sorts. In other words, test some of the Star Trek research from ENTB before advancing it to Regen?
I am still trying to wrap my mind around Bio-Matrix's purpose post Regen IPO before buying more shares. If what I am hypothesizing is true, then it would be rather ingenious because, excuse my fowl terminology, you would have an incubator co, a chick co, and a pullet co--before pharming out major ideas to Tyson (Merck).
Interesting possibilities.
Thus, I deserve a discounted movie ticket. :)
C'mon, at least $1 off.
Agreed. Bought another 50,000 shares today. Could not resist.
I am probably wrong.
15.08 million. My bad.
Go MANU!
I bought another 100,000 shares today. Crossing my fingers.
I heard on NPR news something about football and concussions and spotty research.
I know a guy who could help:
Steven Victor MD @stevenvictormd · Jan 26
Attending #Brewer #Concussion meeting this week....#Stemcells could help these patients
Blackjack,
If the roll out is successful with ROG, and then Ghana signs on, then I think you may very well be right. With 111m shares in float, this stock could be locked and loaded with the right quarterly report.
I see .45 by mid July and $3 by this time next year.
Really?
You know, part of me thinks along this line, but with all the job postings, the co. managers must feel confident in the contract.
What we will see in 10Q.
What a share of Kallo will cost by mid...June?
Predictions?
I do wish they would hurry it along. The CFO position was filled a few weeks ago. Maybe he is getting up to speed.
How long does it take to count 200 million dollars? I mean...really.
We are GREEN!
I believe I am going to wade in tomorrow.
Folks,
Check out KALO (Kallo Corp). They are late on filings, but with a $200,000,000 contract and a website www.kalloinc.ca that suggests MANY jobs posted, my hunch is that a RUN is imminent.
I am locked and loaded. Come join the fun when this runs.
KALO-.075
For those who do not see the connection here, see Regen Medical PC, owned by Dr. Victor, has an alliance with The Stem Cell Institute.
http://www.repairstemcells.org/Old-Content/Resources-1/Stem-Cells-in-the-News/THE-REPAIR-STEM-CELL-INSTITUTE-ANNOUNCES-ITS-ALLIA.aspx
http://www.fiercecro.com/story/inventiv-signs-get-intellicells-regenerative-drug-clinic/2014-04-15
Go SVFC! I am know I cannot WAIT until Tuesday. I'm telling all my friends about the great potential here.
Does anyone know anything about the "in-human clinical studies, including one for lower limb ischemia, which is a vascular disease that affects the arteries supplying blood to the legs?"
MedReps Career Center: Biotechnology Company News
IntelliCell BioSciences wins key listing from FDA
Nov 09, 2012 12:58 PM
In today's challenging healthcare sales market, biotechnology companies face many hurdles when trying to commercialize their products. Now, New York-based IntelliCell BioSciences has announced it has cleared a key roadblock to process its regenerative medicine technology.
The company said it has been notified by the Food and Drug Administration (FDA) that its facility in New York is now registered to recover, process package, store and label human cells and tissues for future development.
"The IntelliCell processing technology is designed to allow physicians to treat their patients during a same day and same procedure basis much the same way that bone marrow transplants and IVF treatments are performed today," Dr. Steven Victor, IntelliCell's chairman and chief executive officer, stated. "This is a significant step for the Company as it continues its mission to be a leading regenerative medicine company."
Although it's unclear whether the facility registration will allow the company to add more biotech sales jobs, it did say it was moving forward with plans for in-human clinical studies, including one for lower limb ischemia, which is a vascular disease that affects the arteries supplying blood to the legs. According to the National Institutes of Health, the condition often leads to amputation.
EXACTLY!
That is why I bought MORE!
NO Brainer. Someone has been accumulating like crazy.
Hmm....BBW, is it you?
Cardiac muscle regrown with Intelicell's cells, which improved heart's ability to shoot blood through the vessels.
Hello??!!!
Screaming BUY!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
You know, with OS that small, this stock could fly with + news.
Time to call the company to inquire about 10Q progress.
So...do I buy when everyone else dumps?
Have to think about this one.
With 5 m at its disposal, I am inclined to believe the company tweet. I had to go back and forth with my lawyer for a week just to buy a house.
So, today in my AP class! I guided students through "The Politics of the English Language" by George Orwell, a staple essay regarding the beauty of language clarity.
Student: I will never need this. I am going to be a nurse.
I then read aloud the recent heart study by Intellicell and ask ed them to explain.
Students: What does this mean?
Me: Spontaneous myocardial replacement means...?
Students: Blank stares, open mouths.
Me: Oh, Come On, please tell me someone knows.
Student: Uh, his heart cells grew back.
Me: Yes!!!!!!
Students: Woaa! That's awesome!
Me: Go tell your grandparents!
Time to spread the word in common language!
Should have listened. Holding for awhile.
Thank you anyway.
Didn't Manu say he wouldn't sell until $5 a share?
I hope that ask at .14 is a sign of a good day to come.
Agreed, TIM.
My hunch is deal with Roche and then the Korean deal announcement. With one or both, SVFC will rock our worlds and change our lives and the lives of those suffering with arthritis...and heart tissue damage...and etc.
46,500 strong--but it would be nice if they could file ON TIME for Ghana's sake!
Makes one wonder what they are waiting for?
And, there has been follow through on the IND.
SVFC is cutting edge and has the attention of the industry. And, is trading in the same range. Insanely cheap when considering the crazy potential as in REGENERATING mycardial tissue.
Buy out or JV imminent--IMHO.
Ladies and Gentlemen,
Prepare for BLAST OFF!
10,9,8,7,6,5,4,3,2,1,
ALL SYSTEMS GO!
Check out the end of the article from May 14.
http://www.thelifesciencesreport.com/pub/na/the-stem-cell-revolution-can-jump-start-your-portfolio-jason-kolbert
Woohoo!
I bought a hundred thousand gallons of water.
Why would you file if you are being bought out?
That is why I bought in, polkat.
TD,
I really think it will happen, especially of we consider the worldwide audience here. Plus, add in Netflix and Amazon, and I think we will be fine.
But, this hurts; it really does. I was sure the bottom was here a few days ago, but...
Hope Springs Eternal.
And, this election in India was no joke. I believe this documentary will bring in some serious revs. as well.